| Beales IL. Efficacy of Helicobacter pylori eradication therapies: a single centre observational study. BMC Gastroenterol 2001; 1:7.Chan FK, Sung JJ, Suen R, Wu JC, Ling TK, Chung SC. Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate-based therapies. Aliment Pharmacol Ther 2000; 14:91-5.De Boer WA, Tytgat GN. Regular review: treatment of Helicobacter pylori infection. BMJ 2000; 320:31-4.Gasbarrini A, Ojetti V, Armuzzi A, Branca G, Canducci F, Torre ES et al. Efficacy of a multistep strategy for Helicobacter pylori eradication. Aliment Pharmacol Ther 2000; 14:79-83.Gomollon F, Ducons JA, Ferrero M, Garcia Cabezudo J, Guirao R, Simon MA et al. Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases. Helicobacter 1999; 4:222-5.Gomollon F, Sicilia B, Ducons JA, Sierra E, Revillo MJ, Ferrero M. Third line treatment for Helicobacter pylori: a prospective, culture-guided study in peptic ulcer patients. Aliment Pharmacol Ther 2000; 14:1335-8.Graham DY, Osato MS, Hoffman J, Opekun AR, Anderson SY, Kwon DH et al. Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study. Aliment Pharmacol Ther 2000; 14:745-50.Huang JQ, Hunt RH. Treatment after failure: the problem of non-responders. Gut 1999; 45 Suppl 1:I40-4.Lerang F, Moum B, Haug JB, Berge T, Tolas P, Sandvei PK et al. Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy. Scand J Gastroenterol 1997; 32:1209-14.Magaret N, Burm M, Faigel D, Kelly C, Peterson W, Fennerty MB. A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy. Dig Dis 2001; 19:174-8.Perri F, Festa V, Andriulli A. Treatment of antibiotic-resistant Helicobacter pylori. N Engl J Med 1998; 339:53.Perri F, Festa V, Clemente R, Quitadamo M, Andriulli A. Rifabutin-based "rescue therapy" for Helicobacter pylori infected patients after failure of standard regimens. Aliment Pharmacol Ther 2000; 14:311-6.Perri F, Festa V, Clemente R, Villani MR, Quitadamo M, Caruso N, et al. Randomized study of two rescue therapies for Helicobacter pylori- infected patients after failure of standard triple therapies. Am J Gastroenterol 2001; 96:58-62.Seppala K, Kosunen TU, Nuutinen H, Sipponen P, Rautelin H, Sarna S, et al. Cure of Helicobacter pylori infection after failed primary treatment: one-center results from 120 patients. Scand J Gastroenterol 2000; 35:929-34.Tompkins DS, Perkin J, Smith C. Failed treatment of Helicobacter pylori infection associated with resistance to clarithromycin. Helicobacter 1997; 2:185-7.Van der Wouden EJ, Thijs JC, Van Zwet AA, Sluiter WJ, Kleibeuker JH. The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis. Am J Gastroenterol 1999; 94:1751-9.Zullo A, Hassan C, Campo SM, Lorenzetti R, Febbraro I, De Matthaeis M et al. A triple therapy regimen after failed Helicobacter pylori treatments. Aliment Pharmacol Ther 2001; 15:1193-7.Zullo A, Hassan C, De Francesco V, Lorenzetti R, Marignani M, Angeletti S, et al. A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication. Dig Liver Dis 2003; 35: 232-6.Zullo A, Hassan C, Lorenzetti R, Winn S, Morini S. A clinical practice viewpoint: to culture or not to culture Helicobacter pylori Dig Liver Dis 2003; 35:357-61. |
| Gisbert JP, Boixeda D, Bermejo F, Nieves Rincon M, Jesus Higes M, Angeles Arpa M et al. Re-treatment after Helicobacter pylori eradication failure. Eur J Gastroenterol Hepatol 1999; 11:1049-54.Gisbert JP, Pajares JM. Helicobacter pylori therapy: first-line options and rescue regimen. Dig Dis 2001; 19:134-43.Gisbert JP, Pajares JM. Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail. Aliment Pharmacol Ther 2002; 16:1047-57.Gisbert JP, Calvet X, Bujanda L, Marcos S, Gisbert JL, Pajares JM. Rescue therapy with rifabutin after multiple Helicobacter pylori treatment failures. Helicobacter 2003; 8:90-94.Gisbert JP, Gisbert JL, Marcos S, Pajares JM. Empirical Helicobacter pylori rescue therapy after failure of two eradication treatments. Dig Liver Dis 2004; 36:7-12.Gisbert JP, Khorrami S, Carballo F, Calvet X, Gene E, Dominguez-Munoz E. Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Aliment Pharmacol Ther 2004; 19:617-29.Gisbert JP, Cruzado AI, Garcia-Gravalos R, Pajares JM. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study. Hepatogastroenterology 2004; 51:303-8.Gisbert JP, Legido J, Garcia-Sanz I, Pajares JM. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs. Dig Liver Dis 2004; 36:116-20.Gisbert JP, Khorrami S, Calvet X, Gabriel R, Carballo F, Pajares JM. Meta-analysis: proton pump inhibitors vs. H2-receptor antagonists-their efficacy with antibiotics in Helicobacter pylori eradication. Aliment Pharmacol Ther 2003; 18:757-66.Gisbert JP, Ducons J, Gomollon F, Dominguez-Munoz JE, Borda F, Mino G, et al. Validation of the 13c-urea breath test for the initial diagnosis of Helicobacter pylori infection and to confirm eradication after treatment. Rev Esp Enferm Dig 2003; 95:121-6, 115-20. |
